Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6221 of 6351
-
Can a simple insole make you jump higher and run faster?
Knowledge-focused Recruiting nowThis study evaluates the effects of VKTRY carbon fiber insoles on vertical jump and sprint performance in moderately active men. Participants will perform tests with and without insoles, assessing both objective performance and subjective perception using a Likert-type scale.
Sponsor: Benjamín Cuenca Valero • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New kidney drug interaction study launches in healthy volunteers
Knowledge-focused Not yet recruitingThis is a open-label, non-randomized, multiple oral dosings, three-period, drug-drug interaction study of JMKX003142 tablet, Amiodarone Hydrochloride Tablets and Febuxostat Tablets in Chinese healthy adult subjects
Phase 1 • Sponsor: Jemincare • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:26 UTC
-
Vitamin B12 injection showdown: are two versions identical?
Knowledge-focused CompletedThis study is a single-center, randomized, open-label, two-period, two-sequence, single-dose, crossover bioequivalence trial conducted under fasting conditions in healthy adult volunteers. Participants will be randomized into two sequences (A and B). Each participant will receive…
Phase 1 • Sponsor: Wanbangde Pharmaceutical Group Co., LTD • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
New drug GEn-1124 tested in just 6 men – first look at how body handles it
Knowledge-focused CompletedThe goal of this clinical trial is to determine the pharmacokinetics (how the body interacts with administered substances for the entire duration of exposure) of Gen-1124 in an oral formulation (taken by mouth) in healthy volunteers. It will also learn about the safety of Gen-112…
Phase 1 • Sponsor: GEn1E Lifesciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Vitamin d deficiency common among young doctors?
Knowledge-focused CompletedRetrospective, observational, and anonymous study to assess vitamin D status in young medical residents of both sexes who joined the staff of the Reina Sofia University Hospital (HURS) in Cordoba, Spain, in March 2020. Subjects with vitamin D deficiency were treated with calcifed…
Sponsor: Maimónides Biomedical Research Institute of Córdoba • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Healthy volunteers help compare two forms of experimental drug
Knowledge-focused CompletedTwo formulations containing the same active pharmaceutical ingredient are considered bioequivalent if their relative bioavailability (rate and extent of drug absorption) falls within acceptable predetermined limits after administration at the same molar dose. Formulations with bi…
Phase 1 • Sponsor: Hutchmed • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Healthy volunteers test new diabetes pill combo
Knowledge-focused CompletedThis study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-383 in healthy volunteers.
Phase 1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Healthy volunteers test HIV drug combo in early safety study
Knowledge-focused CompletedResearchers have designed a new study medicine called MK-4646 as a new way to treat human immunodeficiency virus (HIV). Rifabutin is a medication used to treat tuberculosis (TB). Researchers want to learn about MK-4646 when taken at the same time as Rifabutin. They want to: Me…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Healthy volunteers help test new Drug's safety
Knowledge-focused CompletedThe purpose of this study is to assess the PK profile, safety, and tolerability of atumelnant after single and multiple once daily (QD) oral doses in healthy Japanese and Caucasian adult participants.
Phase 1 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Biscuit study: do fake fats and sugars mess with your gut?
Knowledge-focused CompletedThis study is a randomized, double-blind, crossover trial aiming at evaluating the gastrointestinal tolerance and bowel habits of sugar- and fat- replacer ingredients and blends (maltitol, polydextrose, allulose and EPG)
Sponsor: Mondelēz International, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Healthy volunteers needed to test experimental drug ABBV-1042
Knowledge-focused Recruiting nowThis study will assess the adverse events, tolerability, and how oral ascending doses of ABBV-1042 moves through the body of healthy adult participants.
Phase 1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Promising combo for rectal cancer never got off the ground
Disease control CancelledThis is a prospective single-center, single-arm, open-label, phase II study evaluating the safety, activity, and efficacy of regorafenib in combination with lorigerlimab for the treatment of patients with regrowing or locally recurrent pMMR/MSS localized rectal cancer following T…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Healthy men needed to test drug interaction risks
Knowledge-focused CompletedThis study will evaluate the effects of nirogacestat 100 mg twice daily (BID) on the pharmacokinetics (PK) of a cytochrome P450 (CYP) cocktail.
Phase 1 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Early study tests how new drug moves through healthy bodies
Knowledge-focused CompletedThe main purpose of this study is to measure how much LY4064809 gets into the bloodstream and how long it takes the body to eliminate it in healthy participants. It also looks at safety and tolerability in healthy participants. The study drug will be administered orally. The stud…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Healthy volunteers test two versions of experimental drug
Knowledge-focused CompletedThe purpose of this study is to estimate the relative bioavailability of UCB0022 Formulation 2 (Test) versus Formulation 1 (Reference) in healthy participants following single oral administration.
Phase 1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Physiotherapists quietly quitting? new study investigates
Knowledge-focused CompletedThe COVID-19 pandemic has profoundly impacted all aspects of human life. Health work professsions have faced the risk of infection, adverse working conditions, physical and verbal violence, disparities in workload and payment, limitations to attend social activities, and disrupti…
Sponsor: Regione del Veneto - AULSS n. 7 Pedemontana • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Collagen peptide blood study completed in three healthy women
Knowledge-focused CompletedThis randomized, double-blind, monocentric, five-way cross-over study aims to collect human serum and plasma samples at 1 and 2 hours after ingestion of hydrolyzed collagen peptides. The enriched sera will be used for ex vivo/ in vitro experiments on skin keratinocytes, fibroblas…
Sponsor: Rousselot BVBA • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Healthy volunteers needed to test new inhaler Drug's safety
Knowledge-focused Recruiting nowThis is a Phase I clinical trial evaluating the safety, tolerability, and pharmacokinetic characteristics of single and multiple doses of CPD704 inhalation suspension in healthy Chinese adult subjects.
Phase 1 • Sponsor: Beijing Tide Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New drug TLC-1180 tested in healthy people for first time
Knowledge-focused Recruiting nowThis phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of TLC-1180 after single- and multiple-ascending doses in healthy subjects.
Phase 1 • Sponsor: OrsoBio, Inc • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
Scientists test spinal zaps on healthy volunteers to fine-tune settings
Knowledge-focused OngoingThe goal of this study is to understand how transcutaneous spinal cord stimulation (tSCS) waveform, modulation frequency, and stimulation location impact lower extremity muscle activation and participant comfort in adults without neurologic conditions.
Sponsor: Shirley Ryan AbilityLab • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC